(3)Commission Implementing Regulation (EU) 2022/1480note extended the approval period of the active substances bensulfuron, chlorotoluron, clomazone, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, MCPA, MCPB, prosulfocarb, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, and tebufenpyrad until 31 October 2023, of the active substances chlormequat, propaquizafop, quizalofop-P-ethyl, quizalofop-P-tefuryl and tritosulfuron until 30 November 2023 and of the active substance flumetralin until 11 December 2023.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.